Follow us
HOME
OUR STORY
TRACK RECORD
TEAM
INVESTORS
FUNDS
PORTFOLIO
IMPACT
SFDR
NEWS
CONTACT
No
Yes
Ok
Marco Groot over LSP in het FD
Amsterdam, April 11, 2017
Marco Groot over LSP in het FD
Lees de gehele column:
Een absoluut beter resultaat
Amsterdam, July 11, 2017:
Marco Groot blikt in het FD terug op zijn eerdere positieve aanbeveling op LSP
Lees de gehele column:
Actief beleggen loont
« back to overview
EQT Life Sciences’ portfolio company Cardior Pharmac...
EQT Life Sciences has supported Amolyt since its first...
EQT Life Sciences Leads Tubulis’ Upsized €128 Mill...
EQT Life Sciences leads $42M funding round in Phagenes...
EQT LIFE SCIENCES LEADS €30M SERIES C FUNDING ROUND ...
EQT Life Sciences Co-Leads VectorY’s €129 Million ...
EQT LS portfolio company Nouscom Raises €67.5 millio...
EQT Life Sciences invests in $61 Million financing of ...
EQT Life Sciences Leads €54 Million Upsized Financin...
EQT Life Sciences largest investor in Agomab’s USD 1...
go to archive
back to news overview
Follow us
Menu
HOME
OUR STORY
TRACK RECORD
TEAM
INVESTORS
FUNDS
PORTFOLIO
IMPACT
SFDR
NEWS
CONTACT
No
Yes
Ok
Marco Groot over LSP in het FD
Amsterdam, April 11, 2017
Marco Groot over LSP in het FD
Lees de gehele column:
Een absoluut beter resultaat
Amsterdam, July 11, 2017:
Marco Groot blikt in het FD terug op zijn eerdere positieve aanbeveling op LSP
Lees de gehele column:
Actief beleggen loont
« back to overview
EQT Life Sciences’ portfolio company Cardior Pharmac...
EQT Life Sciences has supported Amolyt since its first...
EQT Life Sciences Leads Tubulis’ Upsized €128 Mill...
EQT Life Sciences leads $42M funding round in Phagenes...
EQT LIFE SCIENCES LEADS €30M SERIES C FUNDING ROUND ...
EQT Life Sciences Co-Leads VectorY’s €129 Million ...
EQT LS portfolio company Nouscom Raises €67.5 millio...
EQT Life Sciences invests in $61 Million financing of ...
EQT Life Sciences Leads €54 Million Upsized Financin...
EQT Life Sciences largest investor in Agomab’s USD 1...
go to archive
back to newsoverview
X
MONTHLY REPORTS
Here you can subscribe for the monthly report of the LSP Life Sciences Fund
First Name:
Last Name:
Email:*
Company: